One of the first painters in the world has highlighted the dangers of bypassing established procedures to assess the safety and efficacy of drugs at the start of a research center at the University of Queensland.
Key points
- The center for UQ innovation in pain and health research aims to improve results for people living with pain
- Center connects 200 UQ pain researchers and supports national and global high profile partnerships
- Speaking at the launch, an international expert has highlighted the importance of clinical research and regulatory procedures.
In a public lecture, the president of the International Union for the Study of Pain (IASP), Professor Andrew Rice, used an analysis of the use of cannabinoids to relieve pain to explain concerns.
The collective work of our hemp work group and the analgesia of cannabinoid represents the most stringent and impartial assessment of both the preclinical and clinical evidence published to date.
We have analyzed 36 randomized controlled tests and came to the conclusion that cannabinoids are not more effective in the treatment of pain than placebos.
At the same time, there are ongoing concerns about adverse effects, including the risk of psychosis syndrome and dependence. ”
Professor Andrew Rice, President of the International Union for the Study of Pain (IASP)
Clinical priority
The Director of the Paul Hodges Health Research and Research Professor Paul Hodges said one of their goals was to conduct high -priority clinical trials to evaluate pain therapies, care models and preventive strategies.
“We are trying to speed up the development of effective interventions so that we can enhance the lives of people affected by pain,” said Professor Hodges.
“A current focus of our work aims to improve the matching the right patient with the right treatment at the right time.
“We do this through the development of new tools to characterize people’s pain, accelerate the translation of treatments by fundamental research into the clinic and applying new ways of treating therapies using smart new types of clinical trials.”
The center officially started by the Minister of Health of the Queensland Tim Nicholls and gathers about 200 researchers at the largest and most different Australian pain research center.
Source:
